In this report, Meddevicetracker covers catalysts from 9 devices expected to occur in Q2 2018. These include important regulatory milestones and trial data across the diabetes, neurology, and cardiovascular spaces. Additionally, at the end of this report we have included a list of Large Impact catalysts through Q2 2018.

For more information on Meddevicetracker, visit its website www.meddevicetracker.com.

Like our report? Have any questions or feedback? Please let us know at mdtaskanalyst@sagientresearch.com.